A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults, Including Read more about A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults, Including
Pre-screening of volunteers for potential participation in future clinical research (observational studies and clinical trials) at KAVI Read more about Pre-screening of volunteers for potential participation in future clinical research (observational studies and clinical trials) at KAVI
Characterization of population specific immune responses in support of HIV vaccine trials Read more about Characterization of population specific immune responses in support of HIV vaccine trials
